Latest Patent law Stories
-Revenues Increased 23 Percent Year to Date- INCLINE VILLAGE, Nev., Aug. 18, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
Patent Trolls: Predatory Litigation and the Smothering of Innovation By Respected Researcher and Attorney William J. Watkins NEW YORK, Aug.
RED BANK, N.J., Aug.
NEW YORK, Aug. 12, 2014 /PRNewswire/ -- Network-1 Technologies, Inc. (OTC BB: NTIP) today announced financial results for the quarter ended June 30, 2014.
Court Denies Apple Motion Alleging Indefiniteness in Markman Ruling ZEPHYR COVE, Nev., Aug.
Includes Recent Corporate Activities and Events NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Finjan Holdings, Inc.
Further strengthens search and analytics capabilities to meet increasing demand from clients around the world ALEXANDRIA, Virginia, August 11, 2014 /PRNewswire/ --
One of Six Patents in Microsoft Lawsuit ZEPHYR COVE, Nev., Aug.
Total of 10 Patents Issued to the Company in 45 Days CAMPBELL, Calif., July 31, 2014 /PRNewswire/ -- hopTo Inc.
RED BANK, N.J., July 31, 2014 /PRNewswire/ -- The Trustees of North European Oil Royalty Trust (NYSE: NRT) announced today a quarterly distribution of $0.46 per unit for the third quarter of
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- A small wooded valley; a dell.
- The protecting weather-shed built around the entrance to a house.